Compound ID | 1250
Class: Tetracycline
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniaeand for the treatment of asymptomatic carriers of Neisseria meningitidis. |
Description: | Semisynthetic sancycline derivative |
Highest developmental phase: | Approved by FDA in 1992 |
Development status: | Approved |
Reason Dropped: | Several drug formulations discontinued |
Chemical structure(s): | |
Canonical SMILES: | CN(C)C1=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C(C=C1)O)O)O)O)C(=O)N)N(C)C |
Isomeric SMILES: | CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C |
InChI: | InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1 |
InChI Key: | FFTVPQUHLQBXQZ-KVUCHLLUSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/54675783 |
External links: | |
Guide to Pharmacology: | minocycline |
Main Source: | https://www.drugbank.ca/drugs/DB01017 |
Citations: |
|